Integra Capital (531314)
Fast GrowerScore breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹21.15 |
| Market Cap | ₹10.02 Cr |
| P/E Ratio | 8.44 |
| ROCE | 0.82% |
| ROE | 20.44% |
| Dividend Yield | 0% |
| Profit Growth | 316.67% |
| Debt/Equity | — |
| Sales Growth | 465.52% |
| 52-Week Range | ₹12.57 — ₹21.15 |
| Sector | Finance |
| Book Value | ₹10.85 |
Strengths
- Return on equity of 20.44% with book value ₹10.85 suggests decent earnings generation on shareholder capital.
- P/E of 8.44 and P/B of 1.95 are not demanding if the current profitability is maintained.
- Latest quarter shows ₹1 Cr net profit on ₹1 Cr sales, with a Piotroski F-Score of 7/9 indicating recent financial health.
- Sales growth of 465.52% and profit growth of 316.67% show momentum, albeit from a tiny base.
Concerns
- Market cap is only ₹10 Cr and quarterly sales are ₹1 Cr, leaving no margin of safety against a business shock and likely poor liquidity.
- Dividend yield is 0.00%, so minority shareholders receive no income, only a claim on future price appreciation.
- Promoter holding is not available, so owner alignment and governance transparency cannot be verified.
- ROCE of 0.82% is far below ROE of 20.44%, raising questions about the true economic return on capital employed.
- The extreme growth rates are mathematical artifacts of a tiny base and cannot be extrapolated.
AI Analysis
At first glance, Integra Capital looks like a statistical bargain: a ₹10 crore market cap, P/E of 8.44, P/B of 1.95, and a 20.44% ROE. Graham would smile, but Buffett would ask: what durable business am I buying? This is a tiny NBFC, not a franchise. Its reported sales jumped 465% and profits 316%, yet the latest quarter still shows only ₹1 crore of sales and ₹1 crore of profit. One crore is not a business; it is a rounding error in the financial system. The PEG ratio of 0.03 assumes 316% profit growth persists forever — that is impossible. Such percentage growth is only because the starting base was negligible. On the balance sheet, book value per share is ₹10.85, so the market is asking a 95% premium over book. That is acceptable only if the 20% ROE is durable and the business can deploy capital at high returns. But ROCE is a miserable 0.82%, and with no promoter-holding data, I cannot assess the owner's skin in the game. There is also no dividend; minority shareholders are being asked to wait for capital gains alone. The Piotroski score of 7/9 is a positive signal, but it tells me about the past year, not the next decade. In Graham's terms, this is a speculative small-cap, not an investment operation with safety of principal. I would need years of audited numbers, a real loan book, and evidenced competitive advantage. At best, I'd take a very small watchlist position; at current scale and disclosure, it's outside my circle of competence.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer